Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

European Cytomegalovirus (CMV) Infection Market Insights, Epidemiology and Market Forecasts 2016-2023 - Research and Markets

Research and Markets
Posted on: 17 Oct 16

Research and Markets has announced the addition of the "Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast -2023 - EU5" drug pipelines to their offering.

EU5Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast 2023 provides an overview of the disease and market size of the CMV for the EU5 (France, Germany, Italy, Spain and United Kingdom) for 2013-2023.

It also includes historical and forecast edepidemiological data for the CMV Prevalent, Diagnosed and Treatable Cases, CMV Patients among Transplants, Infants Patients at High Risk of CMV and HIV Patients at High Risk of CMV from 2013-2023.

The total number of Diagnosed Cytomegalovirus (CMV) infection cases in France is expected to increase at a CAGR of 0.06% to 20,871 cases by 2023. In case of Germany it is expected to increase at a CAGR of 0.067% to 21,619 cases by 2023.

In United Kingdom, the total number of Diagnosed Cytomegalovirus (CMV) infection cases is expected to increase at a CAGR of 0.061% to 14,417 cases by 2023 and in Spain is expected to increase at a CAGR of 0.029% to 12,810 cases in 2023.

For Italy, it is expected to increase at a CAGR of 0.031% to 13,358 cases in 2023. CMV infection is most prevalent in Italy and least prevalent in Spain of the EU5.

As per estimation, the market size of Cytomegalovirus (CMV) infection shall reach to USD 50.2 Million in Italy, USD 213.3 Million in Germany, USD 142.3 Million in France, USD 62.8 Million in Spain and USD 63.8 Million in United Kingdom by the end of 2023. Italy has the lowest and Germany has the highest market size of the EU5.

Key Topics Covered:

  1. Cytomegalovirus Infections
  2. Disease Overview
  3. Symptoms of cytomegalovirus (CMV) Infection
  4. Etiology
  5. Risk Factors
  6. Pathogenesis of human cytomegalovirus
  7. Pathophysiology of cytomegalovirus infection
  8. Diagnosis
  9. Treatment Algorithm for Cytomegalovirus Infections
  10. Treatment for Congenital CMV Infection
  11. Treatment of Ganciclovir resistant CMV
  12. Treatment Guidelines
  13. Recommendations for Treating Cytomegalovirus Infections
  14. Disease Management
  15. Epidemiology and Patient Population

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/v3z7jc/cytomegalovirus

View source version on businesswire.com: http://www.businesswire.com/news/home/20161017005526/en/

Business Wire
www.businesswire.com

Last updated on: 17/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.